文献速递神经康复

机器人手部外骨骼用于卒中后康复的神经可塑性证据:一项随机对照试验

Evidence of neuroplasticity with robotic hand exoskeleton for post-stroke rehabilitation: a randomized controlled trial.
PubMed 文献 · J Neuroeng Rehabil · 2021-05-06

该试点前瞻性平行随机对照研究纳入卒中后2年内患者,比较机器人外骨骼治疗(RG,n=12)与剂量匹配的常规上肢康复(CG,n=11)各20次、每次45分钟、每周5天共4周的效果。结果显示RG在改良Ashworth量表、主动关节活动度和Fugl-Meyer量表(含腕/手分量表)上优于CG,且同侧半球皮层兴奋性显著提高,提示机器人训练可改善运动结局并诱导神经可塑性变化。

要点

  • 机器人外骨骼训练在改良Ashworth量表、主动关节活动度和Fugl-Meyer量表上优于常规康复。
  • RG组同侧半球静息运动阈值下降、运动诱发电位波幅增加,皮层兴奋性显著提高。
  • RG组半球间静息运动阈值不对称性显著改变,提示跨半球可塑性变化。

核心结论

  • 机器人外骨骼训练可改善卒中患者上肢运动结局并提高皮层兴奋性。
  • RG组的神经生理变化最可能源于塑性重组和使用依赖性可塑性。

研究设计与样本

  • 试点前瞻性平行随机对照研究,在临床环境中开展。
  • 纳入卒中后2年内患者,随机分为机器人治疗组(RG,n=12)和常规上肢康复对照组(CG,n=11)。
  • 干预为20次、每次45分钟、每周5天共4周,两组剂量匹配。

主要发现

  • 两组均未报告任何副作用。
  • 除CG组改良Ashworth量表外,两组在所有临床运动结局上均显著改善(p<0.05)。
  • RG组在改良Ashworth量表、主动关节活动度、Fugl-Meyer量表及FM腕/手分量表上显著优于CG(p<0.05)。
  • RG组同侧半球皮层兴奋性较CG显著提高(p<0.05),表现为静息运动阈值降低和运动诱发电位波幅增加。
  • 对侧半球未见显著变化;半球间静息运动阈值不对称性在RG组较CG组出现显著变化(p<0.05)。

关键数值与推荐

  • 临床评估采用改良Ashworth量表、主动关节活动度、Barthel指数、Brunnstrom分期和Fugl-Meyer量表。
  • 神经生理评估采用经颅磁刺激测量运动诱发电位和静息运动阈值。
  • RG组在改良Ashworth量表、主动关节活动度、Fugl-Meyer量表及FM腕/手分量表上较CG组改善显著(p<0.05)。
  • RG组同侧半球静息运动阈值降低和运动诱发电位波幅增加均显著优于CG(p<0.05)。
  • 试验注册号:ISRCTN95291802。

临床怎么用

  • 对于卒中后2年内患者,可考虑使用机器人手部外骨骼进行上肢康复训练。
  • 训练方案可参照每次45分钟、每周5天、共4周共20次,并与常规康复剂量匹配。
  • 疗效评估可结合临床量表与经颅磁刺激神经生理指标,关注同侧半球皮层兴奋性变化。

局限性

  • 本研究为试点研究,样本量较小(RG n=12,CG n=11)。
  • 研究对象限定为卒中后2年内患者,结论外推需谨慎。
  • 原文未报告盲法、分配隐藏及随访时长等设计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A novel electromechanical robotic-exoskeleton was designed in-house for the rehabilitation of wrist joint and Metacarpophalangeal (MCP) joint. OBJECTIVE: The objective was to compare the rehabilitation effectiveness (clinical-scales and neurophysiological-measures) of robotic-therapy training sessions with dose-matched conventional therapy in patients with stroke. METHODS: A pilot prospective parallel randomized controlled study at clinical settings was designed for patients with stroke within 2 years of chronicity. Patients were randomly assigned to receive an intervention of 20 sessions of 45 min each, five days a week for four weeks, in Robotic-therapy Group (RG) (n = 12) and conventional upper-limb rehabilitation in Control-Group (CG) (n = 11). We intended to evaluate the effects of a novel exoskeleton based therapy on the functional rehabilitation outcomes of upper-limb and cortical-excitability in patients with stroke as compared to the conventional-rehabilitation. Clinical-scales- Modified Ashworth Scale, Active Range of Motion, Barthel-Index, Brunnstrom-stage and Fugl-Meyer (FM) scale and neurophysiological measures of cortical-excitability (using Transcranial Magnetic Stimulation) -Motor Evoked Potential and Resting Motor threshold, were acquired pre- and post-therapy. RESULTS: No side effects were noticed in any of the patients. Both RG and CG showed significant (p < 0.05) improvement in all clinical motor-outcomes except Modified Ashworth Scale in CG. RG showed significantly (p < 0.05) higher improvement over CG in Modified Ashworth Scale, Active Range of Motion and Fugl-Meyer scale and FM Wrist-/Hand component. An increase in cortical-excitability in ipsilesional-hemisphere was found to be statistically significant (p < 0.05) in RG over CG, as indexed by a decrease in Resting Motor Threshold and increase in the amplitude of Motor Evoked Potential. No significant changes were shown by the contralesional-hemisphere. Interhemispheric RMT-asymmetry evidenced significant (p < 0.05) changes in RG over CG indicating increased cortical-excitability in ipsilesional-hemisphere along with interhemispheric changes. CONCLUSION: Robotic-exoskeleton training showed improvement in motor outcomes and cortical-excitability in patients with stroke. Neurophysiological changes in RG could most likely be a consequence of plastic reorganization and use-dependent plasticity. Trial registry number: ISRCTN95291802.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Singh N, Saini M, Kumar N, et al. Evidence of neuroplasticity with robotic hand exoskeleton for post-stroke rehabilitation: a randomized controlled trial. J Neuroeng Rehabil. 2021. PMID: 33957937. doi:10.1186/s12984-021-00867-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。